Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN: Symbicort pMDI vs Formoterol in COPD
NCT00206167Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Apr 2005; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00206167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206167.